Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 253, pseudogene (RNU6-253P)
- Target
- RNU6-253P
- Molecular classification
- Other (non-coding RNA pseudogene)
01
Overview
RNU6-253P (RNA, U6 small nuclear 253, pseudogene) is a pseudogene in the human genome related to the gene encoding U6 small nuclear RNA, a component of the spliceosomal snRNP complex. The U6 snRNA gene plays an essential role in the removal of introns from pre-mRNA during splicing, but the RNU6-253P is classified as a pseudogene, meaning it is a non-functional copy and is not believed to have any protein-coding or regulatory activity[3][5]. Pseudogenes such as RNU6-253P may arise through gene duplication or retrotransposition and are generally transcriptionally inactive or have no biological function[4]. There is no evidence that RNU6-253P is expressed or that it has a functional role in human biology or disease. It is not considered a therapeutic target, nor are there drugs or biomarkers associated with it[5][6].
- Other names
- RNU6-253P
02
Biological functions
Other (typically considered non-functional, as pseudogenes are generally not transcribed or translated into active products)
03
Disease associations
Other (no direct disease associations for RNU6-253P; in general, most snRNA pseudogenes such as this are not functionally implicated in disease)
Beyond the preview
Go deeper on RNA, U6 small nuclear 253, pseudogene (RNU6-253P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 253, pseudogene (RNU6-253P).